GJA1 and breast carcinoma: The treatment with Cx43-M2 antibodies anti-Cx43 induced the opening of Cx43 hemichannel in osteocytes, inhibiting cancer cell growth and migration in mouse breast carcinoma, decreasing the levels of immune-suppressive Treg cells and increasing tumor-infiltrating T cells and Th lymphocytes [160].